Mebias Discovery
Mebias Discovery is a Philadelphia-based company specializing in innovative drug discovery and development, with a focus on G Protein Coupled Receptors (GPCRs). Their proprietary membrane protein-NMR drug discovery platform enables the identification of highly selective molecules that bind to GPCR targets, eliminating adverse effects and maximizing therapeutic potential.
With seven years of experience, Mebias Discovery has successfully validated their unique drug discovery platform and identified an FDA-approved Investigational New Drug for the mu-opioid receptor. Additionally, they are currently developing Sphingosine 1-phosphate receptor agonists for the treatment of neuropathic pain.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.